NCT02828865View on ClinicalTrials.gov

A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 18, 2013

Study Completion Date

May 27, 2020

Conditions
Hepatocellular CarcinomaMetastatic Liver Cancers
Interventions
DEVICE

Irreversible Electroporation (IRE) System

Trial Locations (1)

10002

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT02828865 - A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers | Biotech Hunter | Biotech Hunter